Hanson McClain Inc. maintained its position in shares of Colgate-Palmolive Company (NYSE:CL) during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 4,237 shares of the company’s stock at the end of the first quarter. Hanson McClain Inc.’s holdings in Colgate-Palmolive were worth $310,000 at the end of the most recent quarter.
A number of other hedge funds have also bought and sold shares of the company. AlphaMark Advisors LLC increased its stake in Colgate-Palmolive by 452.1% in the first quarter. AlphaMark Advisors LLC now owns 1,673 shares of the company’s stock valued at $122,000 after buying an additional 1,370 shares in the last quarter. North Star Investment Management Corp. boosted its stake in shares of Colgate-Palmolive by 3.9% in the first quarter. North Star Investment Management Corp. now owns 1,797 shares of the company’s stock worth $132,000 after buying an additional 67 shares during the last quarter. Blue Chip Partners Inc. boosted its stake in shares of Colgate-Palmolive by 0.4% in the first quarter. Blue Chip Partners Inc. now owns 1,805 shares of the company’s stock worth $132,000 after buying an additional 8 shares during the last quarter. Advantage Investment Management LLC boosted its stake in shares of Colgate-Palmolive by 16.8% in the first quarter. Advantage Investment Management LLC now owns 1,850 shares of the company’s stock worth $135,000 after buying an additional 266 shares during the last quarter. Finally, Security Asset Management purchased a new stake in shares of Colgate-Palmolive during the fourth quarter worth $131,000. 73.69% of the stock is owned by institutional investors.
Colgate-Palmolive Company (NYSE:CL) opened at 71.02 on Friday. The firm has a market capitalization of $62.56 billion, a P/E ratio of 26.39 and a beta of 0.80. Colgate-Palmolive Company has a 52-week low of $63.43 and a 52-week high of $77.27. The firm’s 50-day moving average is $72.30 and its 200-day moving average is $72.91.
Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings results on Friday, July 21st. The company reported $0.72 earnings per share for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.72. Colgate-Palmolive had a return on equity of 3,121.95% and a net margin of 15.83%. The firm had revenue of $3.83 billion during the quarter, compared to analysts’ expectations of $3.89 billion. During the same quarter in the previous year, the business earned $0.70 earnings per share. The company’s revenue was down .5% on a year-over-year basis. On average, equities analysts expect that Colgate-Palmolive Company will post $2.89 earnings per share for the current year.
The firm also recently declared a quarterly dividend, which was paid on Tuesday, August 15th. Stockholders of record on Tuesday, July 18th were paid a $0.40 dividend. This represents a $1.60 annualized dividend and a dividend yield of 2.25%. The ex-dividend date was Friday, July 14th. Colgate-Palmolive’s dividend payout ratio is currently 59.48%.
ILLEGAL ACTIVITY NOTICE: “Colgate-Palmolive Company (NYSE:CL) Stake Maintained by Hanson McClain Inc.” was first posted by BNB Daily and is the sole property of of BNB Daily. If you are reading this story on another site, it was illegally stolen and reposted in violation of U.S. & international trademark and copyright laws. The legal version of this story can be read at https://www.baseball-news-blog.com/2017/08/19/hanson-mcclain-inc-continues-to-hold-stake-in-colgate-palmolive-company-nysecl-updated-updated.html.
CL has been the subject of a number of analyst reports. Royal Bank Of Canada restated a “hold” rating and issued a $74.00 price objective on shares of Colgate-Palmolive in a research note on Monday, April 24th. Jefferies Group LLC reduced their price objective on shares of Colgate-Palmolive from $78.00 to $76.00 and set a “hold” rating for the company in a research note on Monday, May 1st. UBS AG reiterated a “neutral” rating and set a $78.00 target price (down from $79.00) on shares of Colgate-Palmolive in a research note on Tuesday, May 2nd. Zacks Investment Research cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Wednesday, May 3rd. Finally, Vetr cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and set a $76.67 target price for the company. in a research note on Wednesday, May 17th. Two equities research analysts have rated the stock with a sell rating, twelve have issued a hold rating and two have given a buy rating to the company. Colgate-Palmolive has a consensus rating of “Hold” and a consensus price target of $75.82.
In other news, Director Ellen M. Hancock sold 5,057 shares of the business’s stock in a transaction on Tuesday, August 1st. The stock was sold at an average price of $71.91, for a total value of $363,648.87. Following the completion of the transaction, the director now owns 199,777 shares in the company, valued at $14,365,964.07. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Patricia Verduin sold 3,833 shares of the business’s stock in a transaction on Tuesday, August 15th. The stock was sold at an average price of $71.45, for a total value of $273,867.85. Following the completion of the transaction, the insider now owns 53,173 shares of the company’s stock, valued at approximately $3,799,210.85. The disclosure for this sale can be found here. Insiders sold 221,802 shares of company stock valued at $15,983,976 in the last 90 days. Company insiders own 1.02% of the company’s stock.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Receive News & Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related companies with MarketBeat.com's FREE daily email newsletter.